Selected patients can benefit more from the management of etoposide and platinum-based chemotherapy and thoracic irradiation-a retrospective analysis of 707 small cell lung cancer patients

The management of small cell lung cancer (SCLC) has reached a plateau. Etoposide and platinum-based chemotherapy plus thoracic irradiation remain the standard treatment strategy for SCLC. Our study aims to assess the potential prognostic factors of patients treated with etoposide and platinum-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Shoubo, Jin, Shi, Shen, Jing, Cao, Jingyan, Zhang, Hua, Meng, Qingwei, Wang, Chunyan, Zhang, Aiqi, Zhang, Pei, Yu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352430/
https://www.ncbi.nlm.nih.gov/pubmed/28055965
http://dx.doi.org/10.18632/oncotarget.14395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352430/
https://www.ncbi.nlm.nih.gov/pubmed/28055965
http://dx.doi.org/10.18632/oncotarget.14395

Ejemplares similares